Review
Open access
Aug 2026
CAR‐Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune‐Mediated Inflammation
“controllable spatiotemporal reprogramming” is proposed as a framework linking target specificity, tissue distribution, activity duration, reversibility, manufacturing, and disease‐specific safety requirements to link CAR‐T, CAR‐M, and CAR‐NK platforms.
Peng-Jun Xu, Zhou-Jing Zhang, Jing Jin et al.
· Advancement of science · 0 citations